Meranox 25 mg/ml Oral Suspension for Pigeons

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Fenbendazole

Available from:

Avimedical B.V.

ATC code:

QP52AC13

INN (International Name):

Fenbendazole

Pharmaceutical form:

Oral suspension

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Pigeon (non-food producing)

Therapeutic area:

Anthelmintic

Authorization status:

Authorized

Authorization date:

2017-04-28

Summary of Product characteristics

Revised: June 2022
AN: 01618/2021 & 01620/2021
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
MERANOX 25 mg/ml oral suspension for pigeons
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Per ml:
ACTIVE SUBSTANCE:
Fenbendazole
25 mg
EXCIPIENTS:
Benzyl alcohol (E1519)
20 mg
Azorubine 85% (E122)
12 µg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral suspension
Slightly pink suspension
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Pigeons
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of the following gastro-intestinal nematodes in pigeons:
_-_
Ascaridia spp. (adult stages)
_-_
Capillaria spp. (adult stages)
4.3
CONTRAINDICATIONS
Birds should not be treated with fenbendazole during moulting.
Revised: June 2022
AN: 01618/2021 & 01620/2021
Page 2 of 6
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Parasitic resistance to any particular class of anthelmintic may
develop following
frequent repeated use of an anthelmintic of that class.
In order to prevent reinfestation of the treated animals, it is
important to
carry out environmental control measures, such as disinfection of the
enclosure and food/water bowls, and disposal of substrate/bedding, in
order
to destroy or remove any eggs in the environment.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Use of the product deviating from the instructions in the SPC may
increase the risk of
development of resistance.
Safety of the product has not been investigated in immature pigeons.
Use only
according to the benefit/risk assessment by the responsible
veterinarian.
Safety and efficacy trials of the product were conducted in the
domestic pigeon
(Columba livia). Use in other species of pigeon should be according to
a
benefit:risk assessment by the responsible veterinarian.
Product administration on consecutive days may lead to severe toxic
effects.
Special precautions to be taken by the person administering the
veterinary
medicinal product to animals
This product may be to